Research / NATH / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-26-026427 General Corporate
Debt relative to revenue 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
87.97% · OPTIONAL · VALID
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.12% · OPTIONAL · VALID
Operating cash generation 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
1.76% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
15.03% · CORE · VALID
Inventory pressure 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
2.59% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
34.88% · CORE · NOT_ENOUGH_HISTORY
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
23.43% · CORE · VALID
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.52% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 31 states Self-history eligible
Sep 26, 2021 7/7 normalized Level 3 Dec 26, 2021 7/7 normalized Level 3 Mar 27, 2022 7/7 normalized Level 3 Jun 26, 2022 6/6 normalized Level 3 Sep 25, 2022 6/6 normalized Level 3 Dec 25, 2022 6/6 normalized Level 3 Mar 26, 2023 7/7 normalized Level 3 Jun 25, 2023 6/6 normalized Level 3 Sep 24, 2023 6/6 normalized Level 3 Dec 24, 2023 4/4 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 29, 2024 7/7 normalized Level 3 Dec 29, 2024 7/7 normalized Level 3 Mar 30, 2025 7/8 normalized Level 3 Jun 29, 2025 7/8 normalized Level 3 Sep 28, 2025 7/8 normalized Level 3 Dec 28, 2025 7/8 normalized Level 3 Mar 29, 2026 7/8 normalized Level 3 Jun 28, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 29.71%
Current 87.97%
Delta 58.27% Capex Intensity Decreased
Previous 0.23%
Current 0.12%
Delta -0.10% Cash Generation Decreased
Previous 11.25%
Current 1.76%
Delta -9.50% Growth Increased
Previous 9.37%
Current 15.03%
Delta 5.66% Inventory Pressure Increased
Previous 0.55%
Current 2.59%
Delta 2.04% Margin Increased
Previous 34.27%
Current 34.88%
Delta 0.61% Profitability Increased
Previous 18.57%
Current 23.43%
Delta 4.86% Sbc Intensity Decreased
Previous 0.70%
Current 0.52%
Delta -0.18% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2024
Similarity 72%
Compared 6 dimensions
Coverage 86% Growth 15.0 · Profitability 35.0 · Sbc Intensity 25.0 · Capex Intensity 5.0 · Cash Generation 30.0 · Inventory Pressure 40.0 Jun 29, 2025
Similarity 69%
Compared 7 dimensions
Coverage 100% Growth 45.0 · Profitability 25.0 · Sbc Intensity 30.0 · Capex Intensity 25.0 · Cash Generation 5.0 · Inventory Pressure 50.0 · Balance Sheet Leverage 0.0 Dec 29, 2024
Similarity 68%
Compared 7 dimensions
Coverage 100% Growth 15.0 · Profitability 30.0 · Sbc Intensity 45.0 · Capex Intensity 0.0 · Cash Generation 25.0 · Inventory Pressure 55.0 · Balance Sheet Leverage 15.0 Jun 25, 2023
Similarity 65%
Compared 6 dimensions
Coverage 86% Growth 19.4 · Profitability 15.0 · Sbc Intensity 45.0 · Capex Intensity 5.0 · Cash Generation 30.0 · Inventory Pressure 60.0 Dec 28, 2025
Similarity 65%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Profitability 40.0 · Sbc Intensity 40.0 · Capex Intensity 10.0 · Cash Generation 55.0 · Inventory Pressure 35.0 · Balance Sheet Leverage 15.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.